neoplasm
|
• 26 of 30 mutants develop pancreatic ductal adenocarcinomas
|
mortality/aging
|
• average survival time is 143 days, with a range of 91-191 days
|
endocrine/exocrine glands
|
• 26 of 30 mutants develop pancreatic ductal adenocarcinomas
|


Analysis Tools